Navigation Links
Bio-Rad Helix EIA ENA + Screen Kit

ProductsBio-Rad Helix EIA ENA + Screen Kit
Company Bio-Rad Laboratories
Item Bio-Rad Helix EIA ENA + Screen Kit
Features 
  • 96 Tests Per Kit
    • Description The ANA and ENA assays can be used to screen out patients negative for antinuclear antibodies, which are associated with various systemic rheumatic diseases such as Systemic lupus erythematosus (Lupus), Sjgren's syndrome, mixed connective tissue disease, progressive systemic sclerosis, scleroderma, polymyositis, dermatomyositis, and Raynaud's phenomenon. They can also be used in conjunction with our individual antibody assays to identify specific autoantibodies.
    Info Bio-Rad Laboratories
    Customer Service: 1-800-2-BIORAD
    Web site: http://www.bio-rad.com

    Related medicine products :

    1. Bio-Rad ANA Screen
    2. Bio-Rad Helix EIA ANA Screen Kit
    3. Bio-Rad Helix EIA ANA Screen Bulk Kit
    4. Bio-Rad Helix EIA ENA + Screen Bulk Kit
    5. Bio-Rad Helix EIA ENA Screen Kit
    6. Bio-Rad Helix EIA Lupus Screening Kit
    7. Bio-Rad Helix EIA ENA Screen Bulk Kit
    8. Bio-Rad Platelia Aspergillus EIA
    9. Automatic Tangent Screen
    10. 1-Meter Roll-Up Tangent Screen
    11. Welch Allyn Suresight™ Vision Screener (English)
    Breaking Medicine Technology:Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Drug side effects a key factor in reduced quality of life for kidney transplant patients 61930 1Drug side effects a key factor in reduced quality of life for kidney transplant patients 61930 2Drug side effects a key factor in reduced quality of life for kidney transplant patients 61930 3Insect resistance to Bt crops can be predicted monitored and managed 61927 1Insect resistance to Bt crops can be predicted monitored and managed 61927 2Research and legislation should go hand in hand as much as possible 10861 1Research and legislation should go hand in hand as much as possible 10861 2